25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA, PA
Century Therapeutics Files New Shelf Registration Statement and Prospectus Su...
Reports Full Year 2025 Financial Results and Business Updates
Material disclosure
Unlocking the Value of our Pipeline for January 2026
Investor Presentation
Director Resignation - Carlo Rizzuto Steps Down from Board
Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors
FY 2025
Q3
Q2
Q1
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Amended Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence
Submission Upload
Amended Notice of Proposed Sale of Securities